Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

No consistent PKC inhibition or significant MDR reversal in melanoma patients treated with CGP-41251

Nov. 22, 2000

Nonanticoagulant heparin derivative designed to exert antiangiogenic activity

Nov. 22, 2000

Novel nucleoside transport inhibitors may overcome limitations of dipyridamole

Nov. 22, 2000

First clinical trial results with Oxford Biomedica's MetXia reported

Nov. 22, 2000

Ligand's Targretin recommended for approval by CPMP

Nov. 22, 2000

Photogen Technologies' PH-10 shows promise for PDT in preclinical studies

Nov. 22, 2000

Biological profile of KF-58333, a new hsp90 antagonist derived from radicicol

Nov. 21, 2000

Cytotoxic hydrazones with novel mechanism of action presented at recent cancer meeting

Nov. 21, 2000

MUP-98176: a new hypoxia-selective cytotoxic mustard prodrug

Nov. 21, 2000

Australian company develops recombinant cytokine analogue with significant potential in cancer

Nov. 21, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...